Literature DB >> 15340476

Immunotherapy dispenses with tumor antigens.

Soldano Ferrone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15340476     DOI： 10.1038/nbt0904-1096

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  5 in total

1.  Antitumor immunity can be uncoupled from autoimmunity following heat shock protein 70-mediated inflammatory killing of normal pancreas.

Authors:  Timothy Kottke; Jose Pulido; Jill Thompson; Luis Sanchez-Perez; Heung Chong; Stuart K Calderwood; Peter Selby; Kevin Harrington; Scott E Strome; Alan Melcher; Richard G Vile
Journal:  Cancer Res       Date:  2009-09-08       Impact factor: 12.701

2.  Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma.

Authors:  Jose Pulido; Timothy Kottke; Jill Thompson; Feorillo Galivo; Phonphimon Wongthida; Rosa Maria Diaz; Diana Rommelfanger; Elizabeth Ilett; Larry Pease; Hardev Pandha; Kevin Harrington; Peter Selby; Alan Melcher; Richard Vile
Journal:  Nat Biotechnol       Date:  2012-03-18       Impact factor: 54.908

3.  Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors.

Authors:  Timothy Kottke; Fiona Errington; Jose Pulido; Feorillo Galivo; Jill Thompson; Phonphimon Wongthida; Rosa Maria Diaz; Heung Chong; Elizabeth Ilett; John Chester; Hardev Pandha; Kevin Harrington; Peter Selby; Alan Melcher; Richard Vile
Journal:  Nat Med       Date:  2011-06-19       Impact factor: 53.440

4.  Functional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapse.

Authors:  Nicolas Boisgerault; Timothy Kottke; Jose Pulido; Jill Thompson; Rosa Maria Diaz; Diana Rommelfanger-Konkol; Addie Embry; Dyana Saenz; Eric Poeschla; Hardev Pandha; Kevin Harrington; Alan Melcher; Peter Selby; Richard Vile
Journal:  Mol Ther       Date:  2013-06-11       Impact factor: 11.454

5.  The profile of tumor antigens which can be targeted by immunotherapy depends upon the tumor's anatomical site.

Authors:  Vanesa Alonso-Camino; Karishma Rajani; Timothy Kottke; Diana Rommelfanger-Konkol; Shane Zaidi; Jill Thompson; Jose Pulido; Elizabeth Ilett; Oliver Donnelly; Peter Selby; Hardev Pandha; Alan Melcher; Kevin Harrington; Rosa Maria Diaz; Richard Vile
Journal:  Mol Ther       Date:  2014-07-25       Impact factor: 11.454
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.